Showing of 25 results
University Hospitals Offers Infusion Shown to Delay Progression of Type 1 Diabetes
Innovations in Diabetes & Metabolic Care | Fall 2024
FDA Approval of Islet Cell Transplant Marks Milestone for UH’s Leading Endocrinologist
Innovations in Diabetes & Metabolic Care | Fall 2024 In 2023, the U.S. Food and Drug Administration (FDA) approved Lantidra™ (donislecel), a breakthrough allogeneic (donor) pancreatic islet cellular therapy for individuals with Type 1 diabetes...
Endocrine Side Effects of Cancer Treatment in Type 1 Diabetes
Innovations in Diabetes & Metabolic Care | Summer 2024
Diabetes Technology Helps Manage Insulin Resistance for Patients Undergoing Cancer Treatment
Innovations in Diabetes & Metabolic Care | Summer 2024
Navigating the Gap: Diabetes Support in Emerging Adulthood
Julia Blanchette, PhD, RN, discusses her research on empowering young adults with Type 1 diabetes. From navigating the complexities of health insurance to addressing financial stress, discover how her work is making a difference in diabetes...
Patient-First Care: Reframing the Language of Diabetes
Innovations in Diabetes & Metrabolic Care | Winter 2024
Breaking the Silence: Understanding Diabetes-Related Depression
Innovations in Diabetes & Metabolic Care | Winter 2024
Best Practices for Managing Steroid-Induced Hyperglycemia
Innovations in Diabetes & Metabolic Care | Winter 2024